Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Chemo-refractory Metastatic Melanoma
NCT01216657Phase 2Terminated
- Sponsor
- Krankenhaus Nordwest
- Start
- Mar 2009
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in melanoma, sponsored by Krankenhaus Nordwest. Started Mar 2009; status: terminated.
02
Drugs
sunitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01216657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01216657.